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Abstract:  Alkylglycerols (alkyl-Gro) are ether lipids abundant in the liver of some 
elasmobranch  fish  species such as ratfishes  and some sharks. Shark liver oil from 
Centrophorus squamosus (SLO), or alkyl-Gro mix from this source, have several in vivo 
biological activities including stimulation of hematopoiesis and immunological defences, 
sperm  quality  improvement,  or anti-tumor  and anti-metastasis activities. Several 
mechanisms are suggested for these multiple activities, resulting from incorporation of 
alkyl-Gro into membrane phospholipids, and lipid signaling  interactions.  Natural  
alkyl-Gro mix from SLO contains several alkyl-Gro,  varying by chain length and 
unsaturation. Six prominent constituents of natural alkyl-Gro mix, namely 12:0, 14:0, 16:0, 
18:0, 16:1 n-7, and 18:1 n-9 alkyl-Gro, were synthesized and tested for anti-tumor and  
anti-metastatic activities on a model of grafted tumor in mice (3LL cells). 16:1 and 18:1 
alkyl-Gro showed strong activity in reducing lung metastasis number, while saturated alkyl-
Gro had weaker (16:0) or no (12:0, 14:0, 18:0) effect. Multiple  compounds and 
mechanisms are probably involved in the multiple activities of natural alkyl-Gro. 
Keywords:  alkylglycerols;  shark liver oil;  ether lipids; immunostimulation; anti-tumor 
activities 
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1. Multiple Biological Activities of Alkylglycerols 
Natural 1-O-alkylglycerols (alkyl-Gro) are bioactive ether lipids present in body cells and fluids. 
They are precursors of ether phospholipids, which participate in structures and functions of membranes 
in certain cells such as white blood cells or macrophages. Alkyl-Gro are also found in bone marrow 
lipids and in milk [1]. 
Marine sources of alkyl-Gro such as the liver oil of certain shark species or rat fish (elasmobranch 
fishes) contain high levels of these compounds as a mixture of few species varying by length and 
unsaturation of the alkyl chain [2]. 
The usual  composition of alkyl chains in alkyl-Gro from Greenland shark (Centrophorus 
squamosus) liver oil (SLO) is as follow: 12:0, 1–2%. 14:0, 1–3%; 16:0, 9–13%; 16:1n-7, 11–13%; 
18:0, 1–5%; 18:1n-9, 54–68%; 18:1n-7, 4–6%, and minor species (<1%). 
Beneficial effects of SLO on health have been recognized in traditional medicine of northern 
countries involved in fishing, such as Japan, Norway or Iceland. In these countries, the ancestral use of 
SLO was empirical as strengthening or wound healing medication. 
Experimental studies were performed during the last  century, aiming to demonstrate whether   
alkyl-Gro from SLO had biological properties and beneficial effects. Indeed,  several studies did 
observe interesting effects, such as hematopoiesis stimulation [3], lowering radiotherapy-induced 
injuries [4], reducing tumor growth [5], or improving vaccination efficiency [6,7]. However, in most 
cases, conclusions were mainly impaired by the poor definition of the mixtures used, in terms of purity 
as well as chemical composition. Furthermore, none of these ancient publications studied or even 
suggested mechanisms for alkyl-Gro multiple effects. 
For several decades,  the family of bioactive lipids has grown tremendously, and lipids are not 
anymore seen only as fat and enemy of good health. All cells possess lipids and phospholipids, which 
are essential components of membranes, and membrane lipids are also used as precursors for mediators 
and messengers. Lipids and phospholipids have prominent roles in cell-to-cell communication and in 
intracellular signals as well. Many lipid-derived bioactive molecules are agonists of specific membrane 
receptors: besides prostanoids  and leukotriens, recent discoveries of new lipid mediators include 
docosanoids and many other eicosanoids such as isoprostanes, anandamide, 2-arachidonoylglycerol 
and other natural lipids acting as cannabinoid receptor agonists. Phospholipidic mediators are as well 
numerous, ubiquitous and of first rank interest; they include Platelet-activating Factor (PAF),   
lyso-phosphatidic acid (Lyso-PA), lyso-phosphatidylcholine (Lyso-PC), and shingosine-1-P (SP-1P). 
Several lipids act as intracellular second messengers (diacylglycerols, free fatty acids) or as regulators 
of transcription factors (free fatty acids, Lyso-PA). 
Thus,  many of the signaling pathways involved in cellular  functions and communications are 
dependent on lipids. Where do cell membrane lipids come from? Interestingly, lipids are the single 
biochemical class that allows variability in structure depending on the nutrition. Therefore, one may 
modify, by nutritional supply, the lipid composition of cell membranes and as a result, the structures 
and functions of membrane–derived bioactive lipids. 
The main hypothesis for explaining multiple biological activities of alkyl-Gro was that they may be 
incorporated into cell membrane phospholipids, and from there modify their physical properties such 
as membrane fluidity and antioxidant status [8],  or  alter cell signaling  through the phospholipase Mar. Drugs 2010, 8                       
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pathways.  This concept has already been used in the multiple applications of n-3 fatty acid food 
supplementation. Its extension to alkyl-Gro is clearly a help for understanding their multiple biological 
activities. 
2. Incorporation into Mediators and Second Messengers 
Indeed, alkyl-Gro can be incorporated into the phospholipids of several cell types such as THP1 
monocytes [9],  endothelial cells [10] or blood platelets [11]. In endothelial cells, resulting   
1-O-alkylglycerophospholipids participated in  the production of 1-O-alkyl-2-acylglycerol [10], an 
analog of diacylglycerol (DAG) with inhibiting effect on protein kinase C [12]. In transformed human 
monocyte  THP1 cells, alkyl-Gro were incorporated into 1-O-alkylglycerophosphatidylcholine, the 
precursor of Platelet-activating Factor (PAF) [9], and incorporation of [
3H] alkyl-Gro resulted in the 
production of labeled PAF. Furthermore, alkyl-Gro incorporation resulted in amplifying and extending 
the PAF production level after stimulation [9]. Increasing 1-O-alkyl-2-acyl-glycerophosphocholine in 
membrane phospholipids could also increase the production of active PAF analogs by oxidation of 
unsaturated fatty acid in the 2-position of glycerol [13,14]. 
3. Male Fertility  
Spermatozoa produce PAF, and this mediator plays an important role in sperm physiology with 
respect to capacitation, acrosome reaction and gamete fusion [15,16]. An attractive hypothesis was that 
alkyl-Gro,  which are PAF precursors, might have effects on sperm functions. Indeed,  boar sperm 
treated  in vitro  with a mixture of natural alkyl-Gro had increased  percent motility and velocity 
parameters. Furthermore,  such treated sperm had better fertilization performances when used for 
artificial inseminations [17], and this has found applications in breeding of several mammalian species. 
In vivo studies in boars showed that oral intake of SLO (40 g/day, 28 days) improved sperm motility 
and velocity, together with an increase in the levels of alkyl-Gro in sperm [18]. The possibility of 
improving fertility by oral SLO supplementation is suggested by these data,  however,  needs 
confirmation. 
4. Immuno-Stimulation and Hematopoiesis 
Since, on the one hand, ancient studies had shown that some alkyl-Gro stimulate hematopoiesis [3] 
and antibody production [6], and, on the other hand, alkyl-Gro are found in body fluids including milk 
[1], we hypothesized that oral treatment of pregnant animals could have beneficial effects on offspring 
health. Indeed, oral treatment by SLO in pregnant sows resulted in the amplification of vaccination-
induced raise in specific immunoglobulins in serum of treated sows. This amplification of specific 
antibodies was also observed in colostrum of treated sows, and as expected, in serum of piglets from 
treated mothers. The piglets from treated sows had also higher leukocyte levels by raising populations 
of polymorphonuclear cells, lymphocytes and monocytes [19]. This resulted in an overall improvement 
in offspring health status and growth, however, besides alkyl-Gro activities, some of these beneficial 
effects might also result from the presence of n-3 polyunsaturated fatty acids (PUFA) in SLO [19]. In 
healthy humans, high doses of SLO (15 g/day) for four weeks induced changes in the cytokine profile Mar. Drugs 2010, 8                       
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and antioxidant status of serum together with an increase in total cholesterol and a decrease of its HDL 
fraction. Again, since SLO contained also high proportions of squalene and PUFA, one cannot attribute 
these different effects to alkyl-Gro only [20]. 
5. Anti-Tumor Activities  
Using a model of solid tumor  grafted in mice (Lewis lung carcinoma cells = LLC), we have 
evaluated the anti-tumor effects of oral SLO and of natural alkyl-Gro purified from the same source. 
We found that both treatments reduced significantly the growth of grafted tumors [21]. Furthermore, 
both treatments also reduced the number of pulmonary metastases. These data demonstrated that   
alkyl-Gro are active molecules accounting for anti-tumor activities of SLO. The mechanisms by which 
alkyl-Gro exert these anti-tumor properties may be multiple. To evaluate anti-neoangiogenic activity, 
we measured the density of an endothelial marker in solid tumors grafted in mice. After an alkyl-Gro 
oral treatment as short as five days, we established that the density of von Willebrand factor in grafted 
tumors was decreased by 26% as compared to control group [21]. Anti-neoangiogenic activities might 
be one of the possible mechanisms for anti-tumor activities of alkyl-Gro [22]. Since basic Fibroblast 
Growth Factor (bFGF), is a major angiogenesis stimulator [23], we studied the effect of natural mix of 
alkyl-Gro on endothelial cell proliferation stimulated by bFGF and showed that alkyl-Gro reduced the 
bFGF stimulating effect [24]. 
6. Chemical Synthesis of 1-O-Alkyl-sn-glycerols  
Since most studies describing alkyl-Gro effects were obtained using a mix of several natural 
compounds, it was of interest to explore the activity of each single compound. We synthesized six of 
the major of natural alkyl-Gro mix, namely: (1) AKG 12:0 = 1-O-Dodecyl-sn-glycerol,  (2) AKG   
14:0 = 1-O-Tetradecyl-sn-glycerol,  (3)  AKG 16:0 = 1-O-Hexadecyl-sn-glycerol (chimyl alcohol),   
(4) AKG 18:0 = 1-O-Octadecyl-sn-glycérol (batyl alcohol), (5) AKG 16:1 = 1-O-(Z)-9'-Hexadecenyl-
sn-glycerol, (6) AKG 18:1 = 1-O-(Z)-9'-Octadecenyl-sn-glycerol (selachyl alcohol) (Figure 1). 
Saturated and monounsaturated (S)-1-O-alkylglycerols were synthesized in two  and  four  steps, 
respectively, from (R)-(-)-2,2-dimethyl-1,3-dioxolane-4-methanol. Alkylation of this latter compound 
by 1-bromohexadecane and 1-bromooctadecane under basic conditions (KOH, n-Bu4NBr cat., DMSO,  
60 °C) followed by acetonide cleavage under acid conditions (0.05 equivalent of p-toluenesulfonic acid 
monohydrate in MeOH:H2O 10:1) afforded chimyl and batyl alcohols,  which were purified by 
recrystallization in petroleum ether and methanol,  respectively. Selachyl alcohol and its lower 
homolog, (S)-3-[(9Z)-9-hexadecen-1-yloxy]-1,2-propanediol, were respectively synthesized from oleic 
and  palmitoleic acids. These monounsaturated fatty acids were reduced by Red-Al to oleyl and 
palmitoleyl alcohols. Their mesylation under classic conditions afforded the corresponding mesylates. 
Alkylation of (R)-(-)-2,2-dimethyl-1,3-dioxolane-4-methanol by these mesylates afforded the protected 
targets as acetonides which under the same acid conditions as previously afforded selachyl alcohol and 
(S)-3-[(9Z)-9-hexadecen-1-yloxy]-1,2-propanediol. 
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Figure 1. 1-O-alkyl-sn-glycerols obtained by chemical synthesis. 
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7. Which 1-O-Alkylglycerols Have Anti-Tumor Activities? 
The activities of alkyl-Gro natural mixture and of each of these compounds were compared using 
the same in vivo model of solid tumor grafted in mice, using olive oil treatment as a control [24]. We 
found that AKG 16:1 and 18:1 were the most potent compounds on tumor  growth and lung 
macrometastasis number, while other compounds (AKG 16:0 and 12:0) had weaker activities. We also 
observed that AKG 18:0 did not reduce, but on the contrary, tended to increase tumor growth and 
metastasis number [25]. 
We also observed important variations in spleen weights at the end of the experiment (day 20). In 
non-grafted mice, natural mix of alkyl-Gro had no effect on spleen weights. Tumor graft induced a 
strong increase in spleen weights of the control group. Alkyl-Gro treatments resulted in a reduction of 
spleen weights in most groups, with stronger effects observed in AKG 16:1 and 18:1 groups, in which 
spleen weights decreased to levels similar of those in non-grafted groups. Again, and by contrast with 
the other compounds, spleen weight in AKG 18:0-treated  group was significantly increased as 
compared with olive oil-treated group [25]. 
8. Cytotoxicity and Effects of Alkylglycerols on Endothelial Cell Proliferation 
On  human  umbilical vein endothelial cells (HUVEC), MTT test of cytotoxicity [26] revealed 
absence of cytotoxic effects after 72 hours  at concentrations lower than 20 µM for any synthetic   
alkyl-Gro. At concentrations devoid of cytotoxic effects, synthetic 18:1 and 16:1 alkyl-Gro again had 
the strongest effects on [
3H]-thymidine incorporation into HUVEC, indicating that these two 
unsaturated compounds might have the strongest inhibiting effect on neo-angiogenesis involved in 
tumor development [25]. Mar. Drugs 2010, 8                       
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9. Alkylglycerols and the Blood-Brain Barrier 
Synthetic short chain alkyl-Gro such as 1-O-pentyl sn glycerol are interesting compounds, which 
transiently open the blood brain barrier (BBB), allowing increased crossing of the BBB by therapeutic 
molecules [27,28]. Parenteral 1-O-decyl-sn-glycerol may also increase carbamazepine crossing through 
BBB [29]. Oxidation of the natural unsaturated alkyl-Gro on the double bound could lead to short-
chain alkyl-Gro with putative similar activities. 
10. Concluding Remarks  
Several biochemical and physiological mechanisms may be involved in the multiple effects of alkyl-
Gro. In spermatozoa, the stimulating and protecting effects of natural alkyl-Gro were partially reduced 
in the presence of a PAF-receptor antagonist, indicating that interaction of alkyl-Gro with PAF 
metabolism and/or activities  [17]. In blood platelets, alkyl-Gro partially inhibited the 
PAF-induced release of serotonin in vitro, suggesting that natural alkyl-Gro might act as a partial 
agonist (agonist-antagonist) on the PAF receptor [11]. 
For a long time, it has been established that injection of batyl alcohol in rats and guinea pigs 
increases  the number of erythrocytes, leukocytes or platelets in blood [3,30]; by contrast selachyl 
alcohol—the mono-unsaturated analog of batyl alcohol—is devoid of such activities [30,31], while this 
compound showed strong anti-tumor activities. 
Since alkyl-Gro are found in hematopoietic organs such as bone marrow, one may hypothesize that 
they have an important role in hematopoiesis, and could behave as precursors of PAF, which has 
stimulating functions in bone marrow cell lines [32,33]. Active PAF-analog production could also 
result from oxidation and cleavage of poly-unsaturated fatty acids at  the  sn-2 position of the   
1-O-alkylphospholipids [13,14]. 
In pigs, oral SLO increased both hematopoiesis and immunoglobulin  production. These effects 
could also be part of the mechanisms involved in anti-tumor effects of alkyl-Gro by raising immuno-
competent cell populations. Furthermore, alkyl-Gro have been shown to activate macrophages in vivo 
[34], but only in the presence of non-adherent B an T cells  in vitro,  suggesting multi-factorial  
cell-to-cell interactions [35]. Direct stimulating activity of alkyl-Gro on calcium signaling in human 
Jurkat T lymphocytes has also been observed in vitro [36]. 
Among the synthetic compounds tested, the anti-tumor  and anti-metastasis activities of natural 
alkyl-Gro from SLO are mostly supported by the unsaturated compounds,  which have 16 and 18 
carbon alkyl chains. These activities are associated with a strong reduction of tumor-induced increase 
in spleen weight. These two compounds represent mainly 70 to 80% of total alkyl-Gro from SLO, 
explaining activity of natural mix of alkyl-Gro. However, the natural mix contains a minor compound, 
AKG 18:0 which has remarkable opposite effects on spleen weight. Therefore the use of the two most 
active compounds could be of interest for improving anti-tumor and anti-metastasis efficiency of alkyl-
Gro. The splenomegaly observed after 3LL cell graft reflects spleen invasion by immature myeloid 
cells, predominantly neutrophil granulocytes, and is associated with a decrease in blood B and T 
lymphocytes [37,38], both events impairing efficient immune responses to tumor cells. Amplification 
of this response by the hematopoietic effect of batyl alcohol might explain spleen size rise induced by Mar. Drugs 2010, 8                       
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this compound together with its inactivity on tumor growth and metastasis. The mechanism of spleen 
size reduction observed in grafted mice treated with AKG 18:1 and 16:1 is poorly understood; it could 
however contribute to restore immune defenses against tumor cells. Activities of products resulting 
from double bound oxidation could be part of the difference between unsaturated versus saturated 
alkyl-Gro anti-tumor activities. 
Mechanisms of anti-tumor effects could also be related to anti-angiogenic activities, since both 
unsaturated alkyl-Gro reduced endothelial proliferation, which is involved in neo-angiogenesis. 
Several biochemical mechanisms could be involved in the multiple activities of alkyl-Gro. Their 
role in increasing PAF precursor and amplifying PAF production [9] could explain effects related to 
PAF activities.  These activities include inflammation and sperm functions, but also immune-
regulations [39,40]. Another interesting track is the interaction of 1-O-alkyl-2-acylglycerol with protein 
kinase C. This compound, which is produced following cell stimulation after alkyl-Gro incorporation 
in membrane phospholipids [10], is an analog  of DAG which inhibits PKC [12];  
1-O-alkyl-2-acylglycerol binds to, but do not activates PKC-ε and competes with DAG [41]; this could 
result in cell growth arrest as observed in endothelial cells [21].  Although  the relation between 
unsaturation and anti-tumor activities of alkyl-Gro remains poorly understood, it appears that each 
molecule may have specific mechanism of action and particular activities.  
Patents: WO 2006/024742, USA 11/453/309, FR n°0953443. 
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